Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023

BUY
$117.37 - $139.17 $2,816 - $3,340
24 New
24 $3,000
Q4 2021

Jan 14, 2022

SELL
$142.57 - $190.86 $712 - $954
-5 Closed
0 $0
Q3 2021

Oct 21, 2021

BUY
$142.45 - $169.82 $712 - $849
5 New
5 $1,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Farmers & Merchants Investments Inc Portfolio

Follow Farmers & Merchants Investments Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farmers & Merchants Investments Inc, based on Form 13F filings with the SEC.

News

Stay updated on Farmers & Merchants Investments Inc with notifications on news.